Skip to content
Screener

Medtronic MDT Reportable segment net sales — Net Sales

Other segment segments

Cardiovascular
$3.8B+13.8%
Neuroscience
$2.75B+5.0%
Medical Surgical
$2.39B+8.0%
Diabetes
$838M+15.1%
Other Operating Segments
$135M—
Other operating segment
$32M0.0%

Similar metrics at other companies

Lowe's Companies logo
LOWReportable Segment — Net Sales
$21.32B+1.9%
Target logo
TGTReportable Segment — Net Sales
$25.44B+6.7%
Dollar Tree logo
DLTRReportable Segment — Net Sales
$4.97B+7.2%
BellRing Brands logo
BRBRReportable Segment — Net Sales
$598.7M+1.8%
OLP
OLPXReportable Segment — Net Sales
$99.37M+2.5%
The Buckle logo
BKEReportable Segment — Net Sales
$288.74M+6.1%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$109.98B-3.9%
Enterprise value$137.24B-3.3%
P/E22.9×-1.7×
P/S3×-0.3×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Medtronic’s 10-K, filed June 18, 2026.

Filed
Jun 18, 2026, 4:27 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-044354
(in millions)Worldwide / Fiscal Year / 2026Worldwide / Fiscal Year / 2025Worldwide / Fiscal Year / 2024
Surgical & Endoscopy6,7646,4986,508
Acute Care & Monitoring2,0511,9091,908
Medical Surgical8,8158,4078,417
Reportable segment net sales33,07930,73429,654
Diabetes3,1122,7552,488
Other operating segment(1)135137221
Other adjustments(2)39(90)—
Total net sales$36,364$33,537$32,364

Item 8. Financial Statements and Supplementary Data

FAQ

What is Medtronic's reportable segment net sales — net sales?
Medtronic (MDT) reported reportable segment net sales — net sales of $6.66B in Q1 2026.
How has Medtronic's reportable segment net sales — net sales changed year-over-year?
Medtronic's reportable segment net sales — net sales increased by 8.5% year-over-year, from $6.14B to $6.66B.
What is the long-term trend for Medtronic's reportable segment net sales — net sales?
Over 4 years (2022 to 2026), Medtronic's reportable segment net sales — net sales has grown at a 1.7% compound annual growth rate (CAGR), from $30.96B to $33.08B.
What does reportable segment net sales — net sales mean?
This metric represents the aggregate revenue generated from all of the company's primary business segments, excluding intersegment eliminations and corporate adjustments. It serves as a comprehensive measure of the top-line performance across the organization's core therapeutic and medical device product lines. By aggregating these segments, investors can assess the total market demand for the company's specialized medical technologies.

Ask your AI about Medtronic's reportable segment net sales — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude